Search

everythinglearnresearchcommunity

for

Search:↓

A 20-year-old woman was found to have a rare ovarian tumor causing symptoms like acne and a low-pitched voice, which disappeared after the tumor was removed.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Removing both ovaries treated the woman's excess male hormone symptoms.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

New treatments for excessive hair growth in women, including advanced drugs and nanotechnology, show promise for better results.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Ketoconazole can treat ovarian hyperandrogenism but should be used cautiously with monitoring and birth control.